Infection by the protozoan Trypanosoma cruzi causes Chagas disease cardiomyopathy
(CCC) and can lead to arrhythmia, heart failure and death. Chagas disease affects 8 million …

SciELO - Brazil - Diretriz da SBC sobre Diagnóstico e Tratamento de Pacientes com
Cardiomiopatia da Doença de Chagas – 2023 Diretriz da SBC sobre Diagnóstico e Tratamento …

Chronic chagasic cardiomyopathy (CCC) develops years after acute infection by
Trypanosoma cruzi and does not improve after trypanocidal therapy, despite reduction of …

Chronic Chagas disease cardiomyopathy (CCC), an especially aggressive inflammatory
dilated cardiomyopathy caused by lifelong infection with the protozoan Trypanosoma cruzi …

The protozoan parasite Trypanosoma cruzi causes Chagas disease, an important public
health problem throughout Latin America. Current therapeutic options are characterised by …

Over 100 years have elapsed since the discovery of Chagas disease and there is still much
to learn regarding pathogenesis and treatment. Although there are antiparasitic drugs …

Among the chemokines discovered to date, nineteen are presently considered to be relevant
in heart disease and are involved in all stages of cardiovascular response to injury …

Host and parasite diversity are suspected to be key factors in Chagas disease pathogenesis.
Experimental investigation of underlying mechanisms is hampered by a lack of tools to …

Chagas disease, a neglected disease caused by the protozoan Trypanosoma cruzi, is
endemic in 21 Latin American countries, affecting 6–8 million people. Increasing numbers of …

Chagas disease (CD) affects approximately 6–7 million people worldwide, from which 30%
develop chronic Chagas cardiomyopathy (CCC), usually after being asymptomatic for years …